Clinical Trial Disclosure
In today’s dynamic regulatory landscape, skilled regulatory medical writing and pharmacovigilance services can add a lot of value to an organization’s overall goal.
WE CAN HELP...!
MEET US
DISCUSS WITH US
GET SOLUTION
Clinical Trial Disclosure
- Anonymization Report and Redacted Reports as per EMA Policy 0070
- Protocol and Results Disclosure to Clinicaltrials.gov, EudraCT, and Local Registries
- Lay Person Summary (LPS)